Paediatric Parapneumonic Empyema in Germany First Results on the Therapeutic Management from a Nationwide Surveillance Study

Segerer F¹, Hagemann C¹, Keller S¹, Schoen C², van der Linden M³, Streng A¹, Rose MA⁴, Liese J^{1 1} Paediatric Infectious Diseases and Immunology, University Children’s Hospital Würzburg, Germany. ² Institute of Hygiene and Microbiology, University of Würzburg, Germany. ³ National Reference Center for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, Germany. ⁴ Children’s Hospital, University of Frankfurt, Germany.   Introduction   •Parapneumonic effusions and pleural empyema (PPE/PE) in children are rare complications of mainly bacterial pneumonias. •Streptococcus pneumoniae and Staphylococcus aureus are the most important pathogens •There are no systematically evaluated data on the therapeutic management of this rare disease in Germany.   Study Objectives •Evaluation of the current therapeutic practice in PPE/PE •Assessment of bacteriological pathogens in children with PPE/PE (see Poster No. 89). •Evaluation of the outcome and persistent sequelae •Identification of risk factors for a severe course and surgical procedures  

Part of Session

Bacterial infections